Researchers have found evidence that taking melatonin for a year or more is associated with a higher risk of heart failure.

Rybelsus is now FDA-approved for managing cardiovascular health. Doctors say oral GLP-1s may reduce heart attack and stroke ...

Researchers found that adults who took melatonin for more than a year had a higher risk of heart failure, but not because of the supplement itself.

New research reveals stem cell therapy significantly lowers heart failure risk in heart attack survivors. Patients receiving ...

A new experimental therapy helps restore the heart’s flexibility in models of stiffened heart failure. Michael Gotthardt and his colleagues at the Max Delbrück Center are working with U.S. researchers ...

SGLT2 inhibitors represent one of the most remarkable therapeutic developments in heart failure care, transitioning from ...

Researchers at the Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, and the University of Utah School of Medicine, have demonstrated that a gene therapy can ...

People who receive stem cell therapy within a week of their first heart attack have nearly a 60 per cent lower risk of ...

Heart failure (HF) is one of the leading causes of death and disability worldwide, affecting millions of people and placing ...

Recently a relative faced a harrowing differential diagnosis: The fluid in his lungs could be cancerous. We were all worried.

Over the last decade, heart failure has risen by more than 900% when it comes to mortality in adults under the age of 45.

UAB has earned the 2025 Outstanding Heart Failure Care Team Award for its nurse-led, interprofessional approach to improving ...